Write a 100-350 word essay about the enzyme human MAN1B1. Provide information related to enzyme: i) function, ii) reaction pathways, ii) Location, and iv) diseases. In writing include these four subheadings

### Function
Human MAN1B1, or endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase, is an enzyme critical in the process of N-glycosylation, specifically in the quality control system of protein folding. MAN1B1 catalyzes the trimming of a single alpha-1,2-linked mannose residue from misfolded glycoproteins within the endoplasmic reticulum (ER). This trimming marks these proteins for degradation, a process known as ER-associated degradation (ERAD), ensuring that only properly folded proteins proceed through the secretory pathway.

### Reaction Pathways
MAN1B1 functions in the N-glycan processing and protein quality control pathways. It trims the terminal mannose residue from high-mannose oligosaccharides on misfolded glycoproteins, which is a signal for their recognition by the ERAD pathway. This action prevents the accumulation of misfolded or improperly glycosylated proteins, which could otherwise aggregate and cause cellular stress. MAN1B1’s role is crucial in maintaining the balance between protein synthesis, folding, and degradation within the ER, ensuring cellular homeostasis.

### Location
MAN1B1 is localized in the endoplasmic reticulum, the cellular organelle responsible for protein synthesis, folding, and initial glycosylation. Its ER localization allows MAN1B1 to monitor and trim misfolded glycoproteins early in their maturation process. By functioning within the ER, MAN1B1 plays a key role in the early stages of glycoprotein quality control, ensuring that only properly folded proteins are allowed to move forward through the secretory pathway.

### Diseases
Mutations in the MAN1B1 gene are associated with a rare genetic disorder known as MAN1B1-CDG (congenital disorder of glycosylation). This condition leads to a spectrum of symptoms, including intellectual disability, developmental delays, skeletal abnormalities, and facial dysmorphisms. The disease arises from the accumulation of improperly folded glycoproteins due to defective mannose trimming, which impairs the ERAD pathway and leads to cellular dysfunction. Understanding MAN1B1’s role in glycoprotein quality control is essential for developing therapeutic strategies for MAN1B1-CDG and other disorders related to protein misfolding and glycosylation defects.